E-mail: m.spacek@fnkv.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- AML z pohledu morfologie a průtokové cytometrie
- Analýza membránové a relativní genové exprese proteinu tepelného šoku Hsp70 u akutní leukémie.
- Cyclin D1 mRNA Expression In CLL: a Pilot Study
- Delta Ex6, the Novel Transactivation-Defective Splicing Variant of p53 Gene, Is Differentially Expressed in Patients with Chronic Lymphocytic Leukemia and Confers Accented Proliferative Phenotype in Vitro
- DELTA EX6, THE NOVEL TRANSACTIVATION-DEFECTIVE SPLICING VARIANT OF TP53, IS DIFFERENTIALLY EXPRESSED IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND CONFERS ACCENTED PROLIFERATIVE PHENOTYPE IN VITRO
- DETECTION OF EBV DNA IN PATIENTS WITH HODGKIN LYMPHOMA IN THE CZECH REPUBLIC: FREQUENCY, QUANTITY IN PLASMA, WHOLE BLOOD AND LYMPH NODE
- DIAGNOSTIC AND THERAPEUTIC APPROACH TO SMALL LYMPHOCYTIC LYMPHOMA (SLL): EXPERIENCE OF CZECH LYMPHOMA STUDY GROUP
- IDENTIFICATION OF A NOVEL, TRANSACTIVATION-DEFECTIVE SPLICING VARIANT OF P53 GENE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
- LOW-DOSE FCR IN THE TREATMENT OF ELDERLY/COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): UPDATED RESULTS OF PROJECT Q-LITE BY CZECH CLL STUDY GROUP
- LOW-DOSE FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINED WITH RITUXIMAB IN THE TREATMENT OF ELDERLY/COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: PROJECT Q-LITE OF CZECH CLL STUDY GROUP
- Low-Dose Fludarabine and Cyclophosphamide Combined with Rituximab In the Treatment of Elderly/Comorbid Patients with chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Preliminary Results of Project Q-Lite by Czech CLL Study Group
- Nové a fenotypicky neobvyklé varianty genu p53 u pacientů s chronickou lymfocytární leukémií
- Ofatumumab retreatment and maintenance in patients with fludarabine-refractory CLL.
